13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7353 | RSV604 | (S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea | RSV |
RSV604 ((S)-1-(2-Fluorophenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)urea) is an inhibitor of respiratory syncytial virus (RSV) that binds to RSV nucleoprotein (Kd = 1.31 μM) | |||
TP1814L | CEF4 acetate | CEF4 acetate(199727-68-9 free base) | Others |
CEF4 acetate (CEF4 acetate (199727-68-9 free base)) is a polypeptide corresponding to amino acid sequence 342-351 of the influenza A virus nucleocapsid protein. | |||
T11409 | GLP-26 | HBV | |
GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools. GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM... | |||
T35841 | 5-Benzyloxygramine | Dopamine Receptor , 5-HT Receptor | |
5-Benzyloxygramine is a N protein PPI orthosteric stabilizer that exhibits both antiviral and N-NTD protein-stabilizing activities[1]. 5-benzyloxygramine stabilizes the N-NTD dimers through simultaneous hydrophobic inter... | |||
T70246 | PD159206 | ||
PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HIV. | |||
TP1814 | CEF4 | ||
CEF4 is a peptide derived from amino acids (aa) 342-351 of the influenza A virus nucleocapsid protein. | |||
T24756 | SAMT-247 | SAMT 247 | |
SAMT-247 is an HIV inhibitor that acts by modifying the nucleocapsid NCp7 region of Gag in infected cells and blocking Gag processing and reducing infectivity. | |||
T61819 | Claficapavir | ||
Claficapavir (A1752) is a potent nucleocapsid protein (NC) inhibitor that effectively binds the HIV-1 NC with a dissociation constant (Kd) of 20 nM, resulting in the inhibition of its chaperone properties. This specific ... | |||
T61613 | SARS-CoV-2-IN-17 | ||
SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of SARS-CoV-2 nucleocapsid protein (NPro). It demonstrates potent anti-viral activity, with an EC50 value of 2.18 μM. Furthermore, SARS-CoV-2-IN-17 binds to ... | |||
T82230 | HCoV-OC43-IN-1 | SARS-CoV | |
HCoV-OC43-IN-1 (Compound IV-16) serves as an inhibitor of the coronavirus HCoV-OC43, exhibiting antiviral efficacy with an EC50 of 90 nM. It effectively inhibits the mRNA levels and expression of the viral nucleocapsid p... | |||
T23407 | Surface antigen (208-215) [Hepatitis B Virus] | Others | |
The nucleocapsid of the hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. The four major subtypes of HBsAg, adw, adr, ayw and ayr, are generat... | |||
T60556 | SARS-CoV-2-IN-16 | ||
SARS-CoV-2-IN-16 (Compound 12) is a potent inhibitor of SARS-CoV-2 nucleocapsid protein (NPro) with potent antiviral activity (EC50 = 3.69 μM). SARS-CoV-2-IN-16 binds to NPro with a low Kd value of 7.82 μM, which suggest... | |||
T10446 | BA-53038B | Others | |
BA-53038B is an HBV core protein allosteric modulator (CpAM), binding to the HAP pocket and modulating HBV capsid assembly in a distinct manner (EC50: 3.32 μM). |